| 000 | 01545 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515160020.0 | ||
| 264 | 0 | _c20091207 | |
| 008 | 200912s 0 0 eng d | ||
| 022 | _a1468-1293 | ||
| 024 | 7 |
_a10.1111/j.1468-1293.2008.00661.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKristoffersen, U S | |
| 245 | 0 | 0 |
_aReduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapy. _h[electronic resource] |
| 260 |
_bHIV medicine _cFeb 2009 |
||
| 300 |
_a79-87 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Retroviral Agents _xadverse effects |
| 650 | 0 | 4 |
_aBiomarkers _xmetabolism |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xchemically induced |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 |
_aRNA, Viral _xdrug effects |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aKofoed, K | |
| 700 | 1 | _aKronborg, G | |
| 700 | 1 | _aGiger, A K | |
| 700 | 1 | _aKjaer, A | |
| 700 | 1 | _aLebech, A M | |
| 773 | 0 |
_tHIV medicine _gvol. 10 _gno. 2 _gp. 79-87 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1468-1293.2008.00661.x _zAvailable from publisher's website |
| 999 |
_c18644421 _d18644421 |
||